文献速递前列腺增生与排尿功能障碍

多中心分析:硬化性苔藓所致阴茎段尿道狭窄的手术治疗——确立单期尿道成形术作为主要治疗选择

Multi-Institutional Analysis of Surgery for Lichen Sclerosus-Induced Penile Urethral Stricture: Establishing Single-Stage Urethroplasty as a Primary Treatment Option.
PubMed 文献 · J Urol · 2025-01-21

9中心多中心分析231例硬化性苔藓所致阴茎段尿道狭窄男性,比较单期口腔黏膜移植尿道成形术、分期尿道成形术与会阴尿道造口术。各术式5年无狭窄复发率分别为82%、76%、75%,复发无差异(P=.6),90天并发症、勃起功能障碍、阴茎弯曲及尿道皮肤瘘均无显著差异;仅肥胖(BMI≥35)与复发相关(HR 2.31)。

要点

  • 单期口腔黏膜移植尿道成形术占55%(127/231),5年无狭窄复发率82%,与分期尿道成形术76%、会阴尿道造口术75%相比无差异(P=.6)。
  • 90天并发症(Clavien≥2)分别为7.1%、16%、8.3%(P=.2),勃起功能障碍、阴茎弯曲、尿道皮肤瘘均无显著差异。
  • 肥胖(BMI≥35)是狭窄复发的唯一相关因素(HR 2.31,95%CI 1.28-4.17;P=.006)。

核心结论

  • 对比结果良好,证实单期尿道成形术对适当选择的硬化性苔藓所致阴茎段尿道狭窄患者高度可行,尤其考虑到所需手术次数更少且保留原位尿道口。

研究设计与样本

  • 9中心多中心分析,纳入接受单期尿道成形术、分期尿道成形术或会阴尿道造口术的硬化性苔藓所致阴茎段尿道狭窄男性231例。
  • 排除尿道口狭窄(<2 cm)、球部尿道受累及全尿道狭窄(>10 cm)。
  • 主要结局为随访评估无复发状态;次要结局包括90天并发症(Clavien≥2)、勃起功能障碍、阴茎弯曲及尿道皮肤瘘。

主要发现

  • 231例中位狭窄长度5 cm,无狭窄复发者中位随访53个月。
  • 1年、5年、10年无狭窄估计分别为90%、80%、75%。
  • 55%(127/231)接受单期口腔黏膜移植尿道成形术,19%(44例)分期尿道成形术,26%(60例)会阴尿道造口术。
  • 对数秩检验示各术式间狭窄复发无差异(P=.6),5年无狭窄估计分别为82%、76%、75%。
  • χ2检验示90天并发症(7.1% vs 16% vs 8.3%;P=.2)、勃起功能障碍(7.1% vs 4.5% vs 3.3%;P=.6)、阴茎弯曲(5.5% vs 6.8% vs 1.7%;P=.4)、尿道皮肤瘘(2.4% vs 6.8% vs 0%;P=.09)均无显著差异。

临床怎么用

  • 作者认为,单期尿道成形术对适当选择的硬化性苔藓所致阴茎段尿道狭窄患者高度可行,尤其考虑到所需手术次数更少且保留原位尿道口。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Ideal treatment of lichen sclerosus (LS)-induced penile urethral strictures (PUS) remains elusive. The objective of this study was to compare multi-institutional outcomes of single-stage urethroplasty (SSU) with oral mucosal graft, staged urethroplasty, and perineal urethrostomy (PU) for treatment of LS-induced PUS. MATERIALS AND METHODS: Multi-institutional analysis was performed at 9 centers on men undergoing SSU, staged urethroplasty, or PU for LS-induced PUS. Meatal strictures (<2 cm), bulbar urethral involvement, and panurethral strictures (>10 cm) were excluded. The primary outcome was recurrence-free status on follow-up assessment. Secondary outcomes included 90-day complications (Clavien ≥2), erectile dysfunction, chordee, and urethrocutaneous fistula. RESULTS: Two hundred thirty-one patients were included with a median stricture length of 5 cm and median follow-up of 53 months among those without stricture recurrence. One-, 5-, and 10-year stricture-free estimates were 90%, 80%, and 75%, respectively. Fifty-five percent (127/231) underwent SSU with oral mucosal graft, 19% (44) staged urethroplasty, and 26% (60) PU. On log-rank, there was no identifiable difference in stricture recurrence between techniques (P = .6) with 5-year stricture-free estimates of 82%, 76%, and 75%, respectively. On χ2, there was no significant difference in 90-day complications (7.1% vs 16% vs 8.3%; P = .2), erectile dysfunction (7.1% vs 4.5% vs 3.3%; P = .6), chordee (5.5% vs 6.8% vs 1.7%; P = .4), or urethrocutaneous fistula (2.4% vs 6.8% vs 0%; P = .09). On Cox regression, only obesity (BMI ≥35) was associated with stricture recurrence (HR, 2.31, 95% CI, 1.28-4.17; P = .006). CONCLUSIONS: Favorable comparative outcomes confirm SSU as a highly feasible treatment for LS-induced PUS in properly selected patients, especially when considering fewer surgeries required and preservation of an orthotopic meatus.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Hengel R, Vanni A, Erickson B, et al. Multi-Institutional Analysis of Surgery for Lichen Sclerosus-Induced Penile Urethral Stricture: Establishing Single-Stage Urethroplasty as a Primary Treatment Option. J Urol. 2025. PMID: 39836868. doi:10.1097/JU.0000000000004434

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。